Literature DB >> 19401181

Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION).

Cheng Zhang1, Yan Guo, Neil R Miller, Steven L Bernstein.   

Abstract

Nonarteritic anterior ischemic optic neuropathy (NAION) results from isolated anterior optic nerve (ON)-axonal ischemia near the retina-optic nerve junction. We utilized a rodent model of NAION (rAION) to study the in vivo inflammatory response after pure axonal ischemic infarct. ON ischemia was generated using laser-coupled rose Bengal dye photoactivation, and the infarct localized using tetrazolium red and histology. ON inflammation was evaluated following infarct using extrinsic macrophage (ED1) and microglial (isolated Iba1) cell markers. In naive ONs, some ED1(+)/Iba1(+) cells, representing extrinsic macrophages, were present in intraretinal ON region, but not in the retroscleral (isolated ON) region. Numerous ED1(-)/Iba1(+) cells, likely representing intrinsic microglia, were present throughout the entire ON. One day post-stroke, slight increases in both ED1(+) and Iba1(+) cells were apparent in the eye region immediately surrounding the anterior ON. Three days post-stroke, there was marked infiltration and aggregates of ED1(+)/Iba1(+) cells, with axon structural disruption in the region of the ischemic infarct. ED1(+) and Iba1(+) cells were present in the portion of the ON surrounding the infarct, possibly representing a penumbral region similar to that seen in ischemic brain infarcts. Although ED1(+) cells decreased by 7-14 days post-stroke, large numbers of Iba1(+) cells persisted in the anterior ON. Similar to other CNS ischemic strokes, pure axonal ischemia results in the early recruitment of extrinsic macrophages to the ischemic region. Manipulation of the inflammatory response may be an important variable that could potentially improve visual outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401181      PMCID: PMC2783225          DOI: 10.1016/j.brainres.2008.12.075

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 2.  Recruiting the immune response to promote axon regeneration in the injured spinal cord.

Authors:  Samuel David; Shalina S Ousman
Journal:  Neuroscientist       Date:  2002-02       Impact factor: 7.519

3.  Robert Feulgen Prize Lecture. Grenzgänger: adult bone marrow cells populate the brain.

Authors:  Josef Priller
Journal:  Histochem Cell Biol       Date:  2003-07-25       Impact factor: 4.304

4.  Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.

Authors:  H Schori; J Kipnis; E Yoles; E WoldeMussie; G Ruiz; L A Wheeler; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target.

Authors:  Mar Castellanos; José Castillo; María M García; Rogelio Leira; Joaquín Serena; Angel Chamorro; Antoni Dávalos
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain.

Authors:  D Ito; K Tanaka; S Suzuki; T Dembo; Y Fukuuchi
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

7.  Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition.

Authors:  Xiaolin L He; J Fernando Bazan; Gerry McDermott; Jong Bae Park; Kevin Wang; Marc Tessier-Lavigne; Zhigang He; K Christopher Garcia
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

8.  Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update.

Authors: 
Journal:  Arch Ophthalmol       Date:  2000-06

Review 9.  Pathogenesis of nonarteritic anterior ischemic optic neuropathy.

Authors:  Anthony C Arnold
Journal:  J Neuroophthalmol       Date:  2003-06       Impact factor: 3.042

10.  Establishment of modified chimeric mice using GFP bone marrow as a model for neurological disorders.

Authors:  Tsuyoshi Furuya; Ryota Tanaka; Takao Urabe; Jun Hayakawa; Makoto Migita; Takashi Shimada; Yoshikuni Mizuno; Hideki Mochizuki
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

View more
  28 in total

1.  Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (rAION).

Authors:  Cheng Zhang; Yan Guo; Bernard J Slater; Neil R Miller; Steven L Bernstein
Journal:  Exp Eye Res       Date:  2010-06-01       Impact factor: 3.467

2.  An Experimental Animal Model of Photodynamic Optic Nerve Head Injury (PONHI).

Authors:  Dimosthenis Mantopoulos; Peggy Bouzika; Athanassios Tsakris; Basil S Pawlyk; Michael A Sandberg; Joan W Miller; Joseph F Rizzo Iii; Demetrios G Vavvas; Dean M Cestari
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

3.  A novel rodent model of posterior ischemic optic neuropathy.

Authors:  Yan Wang; Dale P Brown; Yuanli Duan; Wei Kong; Brant D Watson; Jeffrey L Goldberg
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

Review 4.  Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models.

Authors:  Steven L Bernstein; Mary A Johnson; Neil R Miller
Journal:  Prog Retin Eye Res       Date:  2011-03-02       Impact factor: 21.198

5.  Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model.

Authors:  Cristian Salgado; Fernandino Vilson; Neil R Miller; Steven L Bernstein
Journal:  Arch Ophthalmol       Date:  2011-12

6.  Sustained neuroprotection from a single intravitreal injection of PGJ₂ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy.

Authors:  Neil R Miller; Mary A Johnson; Theresa Nolan; Yan Guo; Alexander M Bernstein; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-08       Impact factor: 4.799

Review 7.  Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses.

Authors:  Steven L Bernstein; Neil R Miller
Journal:  Jpn J Ophthalmol       Date:  2015-02-18       Impact factor: 2.447

8.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

9.  Stroke in the eye of the beholder.

Authors:  Hiroto Ishikawa; Mathew Caputo; Nicholas Franzese; Nathan L Weinbren; Adam Slakter; Milan Patel; Christine E Stahl; Maria Alejandra Jacotte; Sandra Acosta; Giorgio Franyuti; Kazutaka Shinozuka; Naoki Tajiri; Harry van Loveren; Yuji Kaneko; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2013-02-05       Impact factor: 1.538

10.  Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.

Authors:  Bernard J Slater; Fernandino L Vilson; Yan Guo; Daniel Weinreich; Shelly Hwang; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.